BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 21999832)

  • 1. Clinical application of urinary proteomics/peptidomics.
    Albalat A; Mischak H; Mullen W
    Expert Rev Proteomics; 2011 Oct; 8(5):615-29. PubMed ID: 21999832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CE-MS in biomarker discovery, validation, and clinical application.
    Mischak H; Schanstra JP
    Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.
    Schiffer E; Mischak H; Novak J
    Proteomics; 2006 Oct; 6(20):5615-27. PubMed ID: 16991199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes.
    Fliser D; Wittke S; Mischak H
    Electrophoresis; 2005 Jul; 26(14):2708-16. PubMed ID: 15966014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery.
    Kolch W; Neusüss C; Pelzing M; Mischak H
    Mass Spectrom Rev; 2005; 24(6):959-77. PubMed ID: 15747373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine proteomics in clinical applications: technologies, principal considerations and clinical implementation.
    Albalat A; Mischak H; Mullen W
    Prilozi; 2011; 32(1):13-44. PubMed ID: 21822176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary exosomes and proteomics.
    Moon PG; You S; Lee JE; Hwang D; Baek MC
    Mass Spectrom Rev; 2011; 30(6):1185-202. PubMed ID: 21544848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of electrophoresis in disease biomarker discovery.
    Issaq HJ; Veenstra TD
    Electrophoresis; 2007 Jun; 28(12):1980-8. PubMed ID: 17503404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary proteomics based on capillary electrophoresis coupled to mass spectrometry in kidney disease.
    Albalat A; Franke J; Gonzalez J; Mischak H; Zürbig P
    Methods Mol Biol; 2013; 919():203-13. PubMed ID: 22976103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications.
    Zürbig P; Dihazi H; Metzger J; Thongboonkerd V; Vlahou A
    Proteomics Clin Appl; 2011 Jun; 5(5-6):256-68. PubMed ID: 21591267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of urinary proteomics in biomarker discovery.
    Shao C; Wang Y; Gao Y
    Sci China Life Sci; 2011 May; 54(5):409-17. PubMed ID: 21455690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capillary electrophoresis coupled to mass spectrometry for proteomic profiling of human urine and biomarker discovery.
    Zürbig P; Schiffer E; Mischak H
    Methods Mol Biol; 2009; 564():105-21. PubMed ID: 19544019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technology Insight: renal proteomics--at the crossroads between promise and problems.
    O'Riordan E; Gross SS; Goligorsky MS
    Nat Clin Pract Nephrol; 2006 Aug; 2(8):445-58. PubMed ID: 16932479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients.
    von Zur Muhlen C; Schiffer E; Zuerbig P; Kellmann M; Brasse M; Meert N; Vanholder RC; Dominiczak AF; Chen YC; Mischak H; Bode C; Peter K
    J Proteome Res; 2009 Jan; 8(1):335-45. PubMed ID: 19053529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.
    Albalat A; Bitsika V; Zurbig P; Siwy J; Mullen W
    Methods Mol Biol; 2013; 984():153-65. PubMed ID: 23386343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation of neurological biomarkers to clinically relevant platforms.
    Hayes RL; Robinson G; Muller U; Wang KK
    Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary proteomics: a tool to discover biomarkers of kidney diseases.
    Dihazi H; Müller GA
    Expert Rev Proteomics; 2007 Feb; 4(1):39-50. PubMed ID: 17288514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.